Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

ClinicalTrials.gov ID: NCT03759392

Public ClinicalTrials.gov record NCT03759392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure With Reduced Ejection Fraction and Decreased Exercise Tolerance

Study identification

NCT ID
NCT03759392
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cytokinetics
Industry
Enrollment
276 participants

Conditions and interventions

Interventions

  • Omecamtiv Mecarbil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 8, 2019
Primary completion
Nov 7, 2021
Completion
Jan 5, 2022
Last update posted
Mar 6, 2023

2019 – 2022

United States locations

U.S. sites
36
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Alaska Heart and Vascular Institute Anchorage Alaska 99508
Arkansas Cardiology Clinic Little Rock Arkansas 72205
Harbor-UCLA Medical Center Torrance California 90509
South Denver Cardiology Associates, PC Littleton Colorado 80120
Hartford Hospital-University of Connecticut School of Medicine Hartford Connecticut 06102
Holy Cross Hospital - Fort Lauderdale Fort Lauderdale Florida 33308-4603
Broward Research Center - Pembroke Pines Pembroke Pines Florida 33024
Emory University Atlanta Georgia 30322
Community Hospital South, Inc. Indianapolis Indiana 46227
Saint Vincent Medical Group Inc. Indianapolis Indiana 46260
University of Maryland Baltimore Maryland 21201
Massachusetts General Hospital (MGH) - Cardiac Unit Associates Boston Massachusetts 02114-2621
University of Michigan Ann Arbor Michigan 48109
Henry Ford Heart & Vascular Institute Detroit Michigan 48202
McLaren Health Care Corporation Petoskey Michigan 49770
Michigan Heart Ypsilanti Michigan 48197
Saint Luke's Health System Kansas City Missouri 64111
Glacier View Research Institute, Cardiology Kalispell Montana 59901
University of Nebraska Medical Center Omaha Nebraska 68198
Cardiovascular Associates Of The Delaware Valley (Cadv), P.A. - Elmer Physicians Care Center - Elmer Elmer New Jersey 08318
Newark Beth Israel Medical Center Newark New Jersey 07112
NYU Langone Medical Center New York New York 10016
Queens Heart Institute Rosedale New York 11422
Duke University Medical Center Durham North Carolina 27710
Wake Med Health and Hospital Raleigh North Carolina 27610
Wake Forest University School of Medicine Winston-Salem North Carolina 27101
The Ohio State University Columbus Ohio 43210
St. John Clinical Research Institute Tulsa Oklahoma 74104
Oregon Health Portland Oregon 97239
Capital Area Research, LLC Camp Hill Pennsylvania 17011
Penn State Hershey Children's Hospital Hershey Pennsylvania 17033
Lancaster Heart And Stroke Foundation Lancaster Pennsylvania 17603
Greenville Health System Greenville South Carolina 29605
University of Texas - Southwestern Medical Center Dallas Texas 75235
Baylor Scott and White Heart and Vascular Hospital Dallas Texas 75246
Inova Heart and Vascular Institute Falls Church Virginia 22042

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 45 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03759392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03759392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →